Sign Up Today and Learn More About Synchron Stock
Invest in or calculate the value of your shares in Synchron or other pre-IPO companies through EquityZen's platform.
Synchron Stock
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
About Synchron Stock
Founded
2016
Headquarters
Campbell, CA, US
Industries
Manufacturing, Health Care, Information Technology
Synchron Press Mentions
Stay in the know about the latest news on Synchron
사이언스 코퍼레이션, 2.3억 달러 투자유치…망막 임플란트로 BCI 첫 상용화 노린다
wowtale • Mar 08, 2026
Musk, Altman and China are fighting to control a potential $320 billion market for brain implants
morningstar • Feb 27, 2026
Brain Computer Interface Market Poised to Redefine Human–Machine Interaction 2026-2034 | DataM Intelligence
einpresswire • Feb 09, 2026
STAT+: Brain-computer implants are coming of age. Here are 3 trends to watch in 2026
statnews • Dec 29, 2025
Da biggest bucks: The 10 Australian startups which raised a combined $2.74 billion in 2025
startupdaily • Dec 24, 2025
Synchron Management
Leadership team at Synchron
CTO & Founder
Nicholas Opie
Chairman
Martin Dieck
Join now and verify your accreditation status to gain access to:
- Synchron Current Valuation
- Synchron Stock Price
- Synchron Management
- Available deals in Synchron and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Synchron Cap Table and Funding History by Share Class and Liquidity Preferences
- Synchron Revenue and Financials
- Synchron Highlights
- Synchron Business Model
- Synchron Risk Factors
- Synchron Research Report from SACRA Research
Trading Synchron Stock
How to invest in Synchron stock?
Accredited investors can buy pre-IPO stock in companies like Synchron through EquityZen funds. These investments are made available by existing Synchron shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Synchron stock?
Shareholders can sell their Synchron stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
